Biovail Corp
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Biovail Corp. from 1993 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Pharmaceutical preparations, Company sales and earnings, Company earnings/profit
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Stock highlight: Biovail Corp. (BVF-46.10)
Article Abstract:
The effects of Biovail's financial situation on its stock performance are discussed.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2003
Company Profile
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Canada, Pharmaceutical industry, Securities, Company securities, Biovail Corp.
Similar abstracts:
- Abstracts: Peabody Energy. Stock highlight: Peabody Energy Corp. (BTU - 75.37)
- Abstracts: INCO Ltd. Stock highlight: INCO Limited (N-37.12)
- Abstracts: Chemical (basic) industry. Stock Highlight: Lyondell Chemical (Lyo-34.88)
- Abstracts: Spill a few beans. Tough pracitce. Don't get mad, get paid
- Abstracts: Tourism gets a severe acute respiratory syndrome (SARS) shock: industry is facing the bleakest outlook. Back to never-never land
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.